Seek­ing greater gen­der di­ver­si­ty, Al­ny­lam pro­motes four fe­male lead­ers; Paul Hast­ings starts post-On­coMed ca­reer as CEO of stealthy Nkar­ta

→ Con­sis­tent with a goal to fos­ter gen­der di­ver­si­ty in its lead­er­ship ranks, Al­ny­lam has pro­mot­ed four fe­male lead­ers to VP lev­el. Kel­ly Bier­ly is now VP, com­mer­cial coun­sel, pro­vid­ing le­gal sup­port — as she’s done at Ver­tex and Aveo On­col­o­gy — across busi­ness, med­ical and pa­tient af­fairs. Bio­gen and Sanofi vet Leila Jali­nous has as­sumed the role of VP, pro­gram & al­liance man­age­ment with cor­re­spond­ing ex­pan­sion of du­ties from in port­fo­lio strat­e­gy. Ex-Pfiz­er staffer Dawn Jarvis takes the VP po­si­tion in hu­man re­sources, while Mar­i­anne Sweetser, pre­vi­ous­ly of Bio­gen, moves up from di­rec­tor of clin­i­cal drug safe­ty to se­nior dis­tin­guished in­ves­ti­ga­tor.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.